INTUITIVE SURGICAL INC Quarterly Report for Q1 Ended Mar 31, 2024

Summary

Intuitive Surgical Inc. (ISRG) reported strong financial results for the first quarter of 2024, demonstrating robust growth across key operational and financial metrics. Total revenue increased by 11% year-over-year to $1.89 billion, driven by a significant 18% rise in instruments and accessories revenue and an 11% increase in service revenue. The company also saw substantial procedure growth, with da Vinci procedures up 16% and Ion procedures nearly doubling at a 90% increase. This growth is supported by an expanding installed base of da Vinci systems, up 14% year-over-year, and a 61% increase in Ion systems. Despite a slight 2% decrease in systems revenue, attributed to a higher proportion of systems placed under operating leases, the company's operational performance remains strong. Profitability also improved, with operating income increasing by 21% and gross profit margin holding steady at 65.9%. The company ended the quarter with a healthy cash position of $7.32 billion.

Key Highlights

• 1Total revenue grew 11% to $1.89 billion, driven by strong performance in instruments, accessories, and services.
• 2Da Vinci procedures increased by 16% year-over-year, indicating continued adoption and utilization of the company's core robotic surgical systems.
• 3Ion endoluminal system procedures nearly doubled, showing significant traction for the company's newer diagnostic platform.
• 4The installed base of da Vinci systems expanded by 14% to 8,887, with Ion systems growing by 61% to 604, reflecting continued market penetration.
• 5Operating income rose 21% to $469 million, showcasing improved profitability.
• 6Gross profit margin remained strong at 65.9%, demonstrating efficient cost management.
• 7The company ended the quarter with $7.32 billion in cash, cash equivalents, and investments, providing substantial financial flexibility.

Frequently Asked Questions